Aims & Scope
Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.
Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 3.9 |
| 2024 | 4.00 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.326 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 143 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 2987 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 2879 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Dentistry and Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Citation: 659
Authors: Robert L., George, Jerome, Joel, A. Dimitrios, Lisa, Kevin J., Stefan, Everett E., Caroline, Francis, Nabil F., Lara Carmen Iglesias, Robert, Tamara, Naomi, Makoto, Mark, Vijayvel, Li, Maura L.
-
Critical evaluation of diagnostic aids for the detection of oral cancer
Citation: 515
Authors: Mark W., John R., Theodore, Paul M.
-
Oral submucous fibrosis: Review on aetiology and pathogenesis
Citation: 440
Authors: W.M., M.F., Takashi, T.J., Saman
-
Oral cancer prevention and control – The approach of the World Health Organization
Citation: 429
Authors: Poul Erik
-
Epidemiology of HPV-associated oropharyngeal cancer
Citation: 420
Authors: Kristen B., Kristina R., Erich M.
-
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
Citation: 412
Authors: Stephen T.
-
Adenoid cystic carcinoma of the head and neck – An update
Citation: 405
Authors: Andrés, Juan P., Patrick J., Vincent, Asterios, Jennifer L., Primož, Alessandra, Missak, Robert P., Vanni, Afshin, Lester D.R., Alfio